Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.1002/cmdc.202200104
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Biological Evaluation of Tetrahydro‐α‐carbolines as Akt1 Inhibitors That Inhibit Colorectal Cancer Cell Proliferation

Abstract: A series of densely functionalized THαCs were designed and synthesized as Akt1 inhibitors. Organocatalytic [3 + 3] annulation between indolin-2-imines 1 and nitroallylic acetates 2 provided rapid access to this pharmacologically interesting framework. In vitro kinase inhibitory abilities and cytotoxicity assays revealed that compound 3 af [(3S*,4S*)-4-(4-bromo-2fluorophenyl)-9-methyl-3-nitro-1-tosyl-2,3,4,9-tetrahydro-1Hpyrido[2,3-b]indole] was the most potent Akt1 inhibitor, and mechanistic study indicated th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 68 publications
(26 reference statements)
0
0
0
Order By: Relevance
“…Nevertheless, fluorine hydrogen bonds are frequently observed in protein–ligand complexes, particularly if the fluorinated ligand is a small organic molecule. Protein targets include FXIa, μ opioid receptor, YAP:TEAD protein–protein interaction, S1P receptor, Akt1, HIV protease, tyrosinase, Bruton’s tyrosine kinase, Janus kinases, and the SARS-CoV-2 main protease. Thus, hydrogen bonds with fluorine as an acceptor are by no means a marginal phenomenon in protein–ligand systems. Whether they are a driving force for the stability of a protein–ligand complex and can thus be exploited as a design element is, however, questionable.…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, fluorine hydrogen bonds are frequently observed in protein–ligand complexes, particularly if the fluorinated ligand is a small organic molecule. Protein targets include FXIa, μ opioid receptor, YAP:TEAD protein–protein interaction, S1P receptor, Akt1, HIV protease, tyrosinase, Bruton’s tyrosine kinase, Janus kinases, and the SARS-CoV-2 main protease. Thus, hydrogen bonds with fluorine as an acceptor are by no means a marginal phenomenon in protein–ligand systems. Whether they are a driving force for the stability of a protein–ligand complex and can thus be exploited as a design element is, however, questionable.…”
Section: Resultsmentioning
confidence: 99%